MyoKardia Announces Appointment of Marc Semigran, M.D., as Chief Medical Officer
Dec 01, 2016 13:01 pm UTC| Business
Former Medical Director of the Heart Failure and Cardiac Transplant Program at Massachusetts General Hospital to Lead Clinical Development SOUTH SAN FRANCISCO, Calif., Dec. 01, 2016 -- MyoKardia, Inc. (Nasdaq:MYOK), a...
MyoKardia Announces Appointment of Marc Semigran, M.D., as Chief Medical Officer
Dec 01, 2016 13:01 pm UTC| Business
Former Medical Director of the Heart Failure and Cardiac Transplant Program at Massachusetts General Hospital to Lead Clinical Development SOUTH SAN FRANCISCO, Calif., Dec. 01, 2016 -- MyoKardia, Inc. (Nasdaq:MYOK), a...
Union Bankshares Corporation Announces Pricing of Subordinated Notes Offering
Dec 01, 2016 13:01 pm UTC| Business
RICHMOND, Va., Dec. 01, 2016 -- Union Bankshares Corporation (the "Company"), the parent company of Union Bank Trust (the "Bank"), today announced the pricing of its public offering of $150 million of its...
Daktari Awarded $1.3 Million NIH SBIR Grant for HIV Point-of-Care Diagnostic
Dec 01, 2016 13:00 pm UTC| Business
CAMBRIDGE, Mass., Dec. 01, 2016 -- Daktari Diagnostics, a company focused on making “Anywhere. Care.™” a reality with its portable and ultrasensitive immunoassay-based CarePlatform™, today announced it was awarded a...
OmniComm Systems Signs Five-Year, $8.4 Million Contract With Top-Tier Research Hospital
Dec 01, 2016 13:00 pm UTC| Business
FORT LAUDERDALE, Fla., Dec. 01, 2016 -- OmniComm Systems, Inc. (OTCQX:OMCM), a leading global provider of clinical data management technology, has been selected to provide electronic data capture (EDC) services to a...
Celsion Corporation Announces Positive DSMB Review of Phase 1b OVATION Study in Ovarian Cancer
Dec 01, 2016 13:00 pm UTC| Business
LAWRENCEVILLE, N.J., Dec. 01, 2016 -- Celsion Corporation(NASDAQ:CLSN) today announced that the independent Data Safety Monitoring Board (DSMB) has completed its safety review of data from the first four patient cohorts...
Dec 01, 2016 13:00 pm UTC| Business
NEW YORK, Dec. 01, 2016 -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI) a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced two ITI-007...